Should I Buy SEAT? SEAT 2026 Analysis

Should You Buy Vivid Seats Inc (SEAT) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

6.420

1 Day change

-1.38%

52 Week Range

90.500

Analysis Updated At

2026/01/30

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now. Despite a short-term technical upswing, the setup is capped by nearby resistance and the fundamental/Street backdrop is deteriorating (sharp revenue decline, heavy price-target cuts, and insider selling). For an impatient buyer who doesn’t want to wait for cleaner confirmation, SEAT is more of an avoid/hold-than-buy at $7.13.

Technical Analysis

Price/Trend: Short-term momentum is improving, but the stock is running into nearby resistance.

MACD: Histogram +0.109 and expanding > 0 suggests bullish momentum building.
RSI(6): 63.3 (neutral-to-slightly warm), not overbought but also not a deep-value entry.
Moving averages: Converging MAs typically imply indecision/transition rather than a clean trend.
Levels: Pivot 6.717 is the key near-term line. Resistance is close at R1 7.222 then R2 7.533; support at S1 6.213. With price at 7.13, upside looks limited unless it decisively clears 7.22 and holds.
Pattern-based forward odds: Model implies only modest expected drift (next day ~+1.39%, next week ~+0.17%, next month ~+2.08%), which is not compelling for an impatient entry.

Intellectia Proprietary Trading Signals

AI Stock Picker: No signal on given stock today.
SwingMax: No signal on given stock today.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Positioning: Extremely call-heavy open interest (put/call OI ratio 0.01) can be interpreted as bullish positioning, but it can also reflect legacy structures rather than fresh conviction.
Activity: Reported options volume is 0, so there’s no strong real-time sentiment confirmation from current trading flow.
Volatility: IV percentile ~5.6 and IV rank ~0.46 indicate low implied vol vs history (options pricing in relatively muted forward uncertainty). That can be attractive for option buyers, but it also suggests the market is not pricing a near-term catalyst. Overall: Options data does not provide a strong “buy now” confirmation because current volume is absent even though OI is skewed to calls.

Technical Summary

Sell

Buy

Positive Catalysts

supports a short-term bounce case.

Neutral/Negative Catalysts

- Fundamentals weakening: sharp YoY revenue decline and worsening profitability (see financials).
- Competitive environment remains challenging; prior commentary highlighted pressure on GOV and take rates.
- Insider selling: insiders are selling, with selling amount up ~148.15% over the last month (negative signal vs near-term upside).
- Wall Street de-risking: multiple major firms cut price targets dramatically, implying reduced confidence in recovery timing.
- No fresh news in the past week to act as an event-driven catalyst.

Financial Performance

Latest reported quarter: 2025/Q3.

Revenue: $136.37M, down 26.92% YoY (material contraction).
Net income: -$8.53M (worsened meaningfully YoY).
EPS: -1.31, down 263.75% YoY (sharp deterioration).
Gross margin: 57.42%, down 14.22% YoY (margin compression). Takeaway: The latest quarter shows clear negative growth trends (top-line down, margins down, losses worsening), which weakens the case for buying a bounce without stronger evidence of stabilization.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent Street trend: overwhelmingly negative revisions via price-target cuts, with most firms staying Neutral/Hold/Equal Weight and one notable Underperform.

Deutsche Bank: PT cut to $7 from $18 (Hold) — now roughly inline with current price.
Morgan Stanley: PT cut to $9 from $12 (Equal Weight).
Citi: PT cut to $8.50 from $10 (Neutral) and earlier to $10 from $13.
Canaccord/RBC: PTs cut to $12 with Hold/Sector Perform.
BofA: PT cut to $8 from $20 (Underperform).
Benchmark: PT cut to $18 from $26 but maintained Buy (minority bullish view).

Wall Street pros: potential turnaround optionality (CEO transition + possible partner + any easing competition) and upside if GOV stabilizes. Wall Street cons: persistent competitive pressure, degraded near-term outlook, and financial downdraft reflected in repeated target cuts.

Influential trading check: No recent congress trading data available; hedge funds are buying while insiders are selling (net mixed-to-negative signal for a ‘buy now’ decision).

SEAT Should I Buy